134 related articles for article (PubMed ID: 31130499)
1. Co-existing malignant lesions in atypical ductal hyperplasia - Pathology, probability, predictors and prognosis.
Co M; Shek T; Kwong A
Asian J Surg; 2020 Jan; 43(1):240-243. PubMed ID: 31130499
[TBL] [Abstract][Full Text] [Related]
2. The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years.
Allen SD; Osin P; Nerurkar A
Eur J Surg Oncol; 2014 Jul; 40(7):824-9. PubMed ID: 24742589
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting the under-diagnosis of atypical ductal hyperplasia diagnosed by core needle biopsies - A 10-year retrospective study and review of the literature.
Co M; Kwong A; Shek T
Int J Surg; 2018 Jan; 49():27-31. PubMed ID: 29146271
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy.
Deshaies I; Provencher L; Jacob S; Côté G; Robert J; Desbiens C; Poirier B; Hogue JC; Vachon E; Diorio C
Breast; 2011 Feb; 20(1):50-5. PubMed ID: 20619647
[TBL] [Abstract][Full Text] [Related]
5. Type of Architecture, Presence of Punctate Necrosis, and Extent of Involvement in Atypical Ductal Hyperplasia Can Predict the Diagnosis of Breast Carcinoma on Excision: A Clinicopathologic Study of 143 Cases.
Zhang C; Wang EY; Liu F; Ruhul Quddus M; James Sung C
Int J Surg Pathol; 2021 Oct; 29(7):716-721. PubMed ID: 33881947
[TBL] [Abstract][Full Text] [Related]
6. Radiologic and Pathologic Features Associated With Upgrade of Atypical Ductal Hyperplasia at Surgical Excision.
Williams KE; Amin A; Hill J; Walter C; Inciardi M; Gatewood J; Redick M; Wick J; Hunt S; Winblad O
Acad Radiol; 2019 Jul; 26(7):893-899. PubMed ID: 30318287
[TBL] [Abstract][Full Text] [Related]
7. Management of papillary lesions of the breast: can larger core needle biopsy samples identify patients who may avoid surgical excision?
Shamonki J; Chung A; Huynh KT; Sim MS; Kinnaird M; Giuliano A
Ann Surg Oncol; 2013 Dec; 20(13):4137-44. PubMed ID: 23943035
[TBL] [Abstract][Full Text] [Related]
8. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
9. CD133 expressionand clinicopathologic significance in benign and malignant breast lesions.
Liu TT; Li XF; Wang L; Yang JL
Cancer Biomark; 2020; 28(3):293-299. PubMed ID: 32390595
[TBL] [Abstract][Full Text] [Related]
10. Scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia at ultrasound-guided core needle biopsy.
Ko E; Han W; Lee JW; Cho J; Kim EK; Jung SY; Kang MJ; Moon WK; Park IA; Kim SW; Kim KS; Lee ES; Min KH; Kim SW; Noh DY
Breast Cancer Res Treat; 2008 Nov; 112(1):189-95. PubMed ID: 18060577
[TBL] [Abstract][Full Text] [Related]
11. Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patients.
Latronico A; Nicosia L; Faggian A; Abbate F; Penco S; Bozzini A; Cannataci C; Mazzarol G; Cassano E
Breast; 2018 Feb; 37():1-5. PubMed ID: 29032282
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic upgrade of atypical ductal hyperplasia of the breast based on evaluation of histopathological features and calcification on core needle biopsy.
Chen LY; Hu J; Tsang JYS; Lee MA; Ni YB; Chan SK; Tse GMK
Histopathology; 2019 Sep; 75(3):320-328. PubMed ID: 31013355
[TBL] [Abstract][Full Text] [Related]
13. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
Piubello Q; Montemezzi S; D'Atri C
Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
[TBL] [Abstract][Full Text] [Related]
14. Impact of breast MRI in women eligible for breast conservation surgery and intra-operative radiation therapy.
Paudel N; Bethke KP; Wang LC; Strauss JB; Hayes JP; Donnelly ED
Surg Oncol; 2018 Mar; 27(1):95-99. PubMed ID: 29549911
[TBL] [Abstract][Full Text] [Related]
15. Atypical ductal hyperplasia on core needle biopsy: Development of a predictive model stratifying carcinoma upgrade risk on excision.
Salagean ED; Slodkowska E; Nofech-Mozes S; Hanna W; Parra-Herran C; Lu FI
Breast J; 2019 Jan; 25(1):56-61. PubMed ID: 30461131
[TBL] [Abstract][Full Text] [Related]
16. Determination of Factors Associated with Upstage in Atypical Ductal Hyperplasia to Identify Low-Risk Patients Where Active Surveillance May be an Alternative.
Greene AJE; Davis J; Moon J; Dubin I; Cruz A; Gupta M; Moazzez A; Ozao-Choy J; Gupta E; Manchandia T; Kalantari BN; Rahbar G; Dauphine C
Ann Surg Oncol; 2024 May; 31(5):3177-3185. PubMed ID: 38386195
[TBL] [Abstract][Full Text] [Related]
17. Pure flat epithelial atypia identified on core needle biopsy does not require excision.
Liu C; Dingee CK; Warburton R; Pao JS; Kuusk U; Bazzarelli A; Sidhu R; McKevitt EC
Eur J Surg Oncol; 2020 Feb; 46(2):235-239. PubMed ID: 31685259
[TBL] [Abstract][Full Text] [Related]
18. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
Carder PJ; Garvican J; Haigh I; Liston JC
Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
[TBL] [Abstract][Full Text] [Related]
19. Atypical ductal hyperplasia at margin of breast biopsy--is re-excision indicated?
Arora S; Menes TS; Moung C; Nagi C; Bleiweiss I; Jaffer S
Ann Surg Oncol; 2008 Mar; 15(3):843-7. PubMed ID: 17987337
[TBL] [Abstract][Full Text] [Related]
20. Progression risk of columnar cell lesions of the breast diagnosed in core needle biopsies.
Verschuur-Maes AH; Witkamp AJ; de Bruin PC; van der Wall E; van Diest PJ
Int J Cancer; 2011 Dec; 129(11):2674-80. PubMed ID: 21225627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
